A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 10,400 shares of OCUL stock, worth $91,312. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,400
Previous 37,300 72.12%
Holding current value
$91,312
Previous $255,000 64.71%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$6.45 - $9.23 $173,505 - $248,287
-26,900 Reduced 72.12%
10,400 $90,000
Q2 2024

Aug 14, 2024

BUY
$4.2 - $8.69 $156,660 - $324,137
37,300 New
37,300 $255,000
Q3 2023

Nov 14, 2023

SELL
$3.14 - $5.04 $1.01 Million - $1.62 Million
-320,500 Reduced 90.49%
33,700 $105,000
Q2 2023

Aug 14, 2023

BUY
$4.6 - $7.64 $206,079 - $342,272
44,800 Added 14.48%
354,200 $1.83 Million
Q1 2023

May 15, 2023

SELL
$2.79 - $6.27 $34,317 - $77,121
-12,300 Reduced 3.82%
309,400 $1.63 Million
Q4 2022

Feb 14, 2023

SELL
$2.61 - $4.41 $90,045 - $152,145
-34,500 Reduced 9.69%
321,700 $903,000
Q3 2022

Nov 14, 2022

SELL
$4.09 - $6.5 $134,561 - $213,850
-32,900 Reduced 8.46%
356,200 $1.48 Million
Q2 2022

Aug 15, 2022

SELL
$3.01 - $5.22 $890,959 - $1.55 Million
-296,000 Reduced 43.21%
389,100 $1.56 Million
Q1 2022

May 16, 2022

SELL
$4.83 - $7.35 $510,531 - $776,895
-105,700 Reduced 13.37%
685,100 $3.39 Million
Q4 2021

Feb 14, 2022

SELL
$6.16 - $12.07 $1.76 Million - $3.45 Million
-285,500 Reduced 26.53%
790,800 $5.51 Million
Q3 2021

Nov 15, 2021

SELL
$9.7 - $14.34 $1.07 Million - $1.59 Million
-110,800 Reduced 9.33%
1,076,300 $10.8 Million
Q2 2021

Aug 16, 2021

SELL
$13.43 - $19.16 $472,736 - $674,432
-35,200 Reduced 2.88%
1,187,100 $16.8 Million
Q1 2021

May 17, 2021

BUY
$15.82 - $22.11 $2.49 Million - $3.48 Million
157,200 Added 14.76%
1,222,300 $20.1 Million
Q4 2020

Feb 16, 2021

BUY
$7.91 - $22.95 $5.85 Million - $17 Million
740,100 Added 227.72%
1,065,100 $22 Million
Q3 2020

Nov 16, 2020

BUY
$7.36 - $9.87 $2.14 Million - $2.87 Million
291,100 Added 858.7%
325,000 $2.47 Million
Q2 2020

Aug 14, 2020

BUY
$4.67 - $8.95 $158,313 - $303,405
33,900 New
33,900 $282,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $676M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.